Daily Archives

February 22, 2012

Policy Focus: PrEP Could Be A “Game Changer” in Fight Against HIV

By | Health Policy, HIV/AIDS | No Comments
Analysis examines biomedical prevention technology to be reviewed by U.S. Food and Drug Administration by June 15, 2012 Pre-exposure chemoprophylaxis (PrEP)—taking antiretroviral medications to prevent HIV transmission—could be a “game changer” for HIV prevention. PrEP has demonstrated partial efficacy with men who have sex with men (MSM), transgender women, and heterosexuals in several recent studies. Recent modeling of PrEP implementation coupled with scaled up treatment predicts that PrEP could significantly reduce HIV incidence and prevalence. And if PrEP is accompanied by sustained care, behavioral interventions, and safety monitoring, PrEP need not lead to increased sexual risk behavior or drug resistance. 
Read More